iShares JPMorgan USD Emerging Markets Bond ETF vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $91.82 (market cap $12.73B), while RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $38.3 (market cap $63.89B). The key difference: RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) is far larger — about 5× iShares JPMorgan USD Emerging Markets Bond ETF's market cap, and RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) pays a 2.47% dividend while iShares JPMorgan USD Emerging Markets Bond ETF pays none. Which is the better fit depends on your goals.
| EMB | RELX | |
|---|---|---|
Market Cap | $12.73B | $63.89B |
Volume | 9,417,425 | 2,760,502 |
Sector | Fixed Income | Industrials |
52-Week High | $97.74 | $46.80 |
52-Week Low | $90.14 | $27.73 |
Typical Hold Time | 50 Days | — |
Enterprise Value | — | $75.40B |
Dividend Yield | — | 2.47% |
Signals from Pluang's Aura AI — not financial advice
EMB trades at $91.82, up 0.61% today, but technical indicators signal a bearish trend with moving averages and key oscillators showing selling pressure. The stock faces resistance at $92 with support at $91. Recent corporate actions include scheduled dividend payments through October 2026, though key financial ratios remain undisclosed in current data.
Outlook remains cautious as technical weakness overshadows dividend income potential. Risks include broader market volatility from rising bond yields and limited fundamental data visibility. Investors should prioritize monitoring upcoming earnings and institutional positioning for directional clarity amid neutral analyst sentiment.
RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.
The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.
Trailing returns across standard periods
Latest headlines on both assets
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.
Read more on RELX →